register

Medical

$5.9 million research injection in leukaemia, Parkinson’s disease, AMD and epilepsy

Health Industry Hub | June 24, 2020 |

The Morrison Government is investing $5.9 million in eight vital medical research projects to find new and innovative treatments for incurable diseases.

The ground breaking research, funded through our Government’s landmark Medical Research Future Fund (MRFF), aims to harness stem cells to apply personalised treatments for a range of diseases and conditions.

The University of Melbourne will receive $952,000 to investigate a promising experimental therapy for Parkinson’s disease using stem cells to replace the cells lost as the disease progresses.

This ground breaking research is about developing the optimum way of transplanting these cells into the brain.

Stem cells have the potential to treat many types of incurable diseases, bringing hope for new treatments and a cure where previously there was none.

The eight research projects (detailed below) will also help with the development of new practical treatments for Australians with other debilitating conditions including fatty liver disease, skin loss, muscle wasting disorders and age-related macular degeneration (AMD).


News & Trends - Pharmaceuticals

Is the government is gearing up to release the long-awaited response to The New Frontier report?

Government’s long-awaited response to The New Frontier report unveiled after two-year wait

Health Industry Hub | December 1, 2023 |

Pharma News: The Albanese Government has tabled its response to the House of Reps inquiry and The New Frontier report […]

More


News & Trends - Pharmaceuticals

Gilead welcomes HIV Taskforce report and celebrates the 'unsung heroes'

Gilead welcomes HIV Taskforce report and celebrates the ‘unsung heroes’

Health Industry Hub | December 1, 2023 |

Pharma News: On World AIDS Day, the National Association of People with HIV Australia (NAPWHA) and Gilead Sciences Australia have […]

More


News & Trends - Pharmaceuticals

AbbVie secures PBS listing of first therapy for Crohn's disease in seven years

AbbVie secures PBS listing of first therapy for Crohn’s disease in seven years

Health Industry Hub | December 1, 2023 |

Pharma News: AbbVie’s Rinvoq (upadacitinib), a once-daily tablet, has been officially listed on the Pharmaceutical Benefits Scheme (PBS) for adult […]

More


ESG

New report calls on policy integration of sustainability in medical device and pharmaceutical registrations and funding

New report calls on policy integration of sustainability in medical device and pharmaceutical registrations and funding

Health Industry Hub | November 30, 2023 |

ESG: Increasing pressures from diverse stakeholder groups, spanning policymakers, investors, customers, and employees, have elevated Environmental, Social, and Governance (ESG) […]

More


This content is copyright protected. Please subscribe to gain access.